compounded semaglutide ban update F.D.A. officials warn of fake weight loss drugs and ban compounded versions Drug compounders sue FDA over

In obesity, outcomes are shaped not only by efficacy, but by how easily patients can start and stay on treatment making convenience a meaningful competitive lever

Seattle (WA) (1993)

In the Phase 2 obesity trial, retatrutide 12 mg produced approximately 24.2% mean weight loss at 48 weeks ( Jastreboff et al., NEJM 2023 ), and the Phase 2 type 2 diabetes trial showed strong HbA1c and weight reductions ( Rosenstock et al., Lancet 2023 )

The Ozempic Lawsuit is ongoing, and our lawyers are accepting new clients

This finding pulls together several threads that Simply Salvia has covered across multiple posts: the UC Berkeley sleep-GH research, the weight loss short dives discussion of why sleep deprivation impairs body composition, and the hair loss short dives note about GHs role in follicle repair and cell division